尿肝型脂肪酸结合蛋白升高作为预测对比剂诱导的急性肾损伤发生的因素以及通过右心房采血血液透析滤过对其的降低作用。
Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.
作者信息
Katoh Hiromasa, Nozue Tsuyoshi, Kimura Yuya, Nakata Sei, Iwaki Taku, Kawano Mitsuhiro, Kawashiri Masa-Aki, Michishita Ichiro, Yamagishi Masakazu
机构信息
Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, Yokohama, 247-8581, Japan,
出版信息
Heart Vessels. 2014 Mar;29(2):191-7. doi: 10.1007/s00380-013-0347-9. Epub 2013 Apr 20.
Although contrast-induced acute kidney injury (CI-AKI) has a great impact on patients' prognosis, few data exist regarding predictors of CI-AKI in patients with severe renal dysfunction who have undergone contrast angiography. Therefore, we prospectively studied 25 patients with renal dysfunction, which was defined as the estimated glomerular filtration rate (eGFR) level <45 ml/min/1.73 m(2), undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI). We performed hemodiafiltration with blood suction from the right atrium (RA-HDF). The mean level of urinary liver-type fatty acid-binding protein (L-FABP) at baseline was significantly higher in the CI-AKI group than in the non-CI-AKI group (59.8 ± 45.6 vs 13.4 ± 11.9 μg/gCr, P = 0.0003). Multivariate regression analysis demonstrated that baseline urinary L-FABP was an independent significant predictor of CI-AKI (β = 0.741, P = 0.013). Receiver-operating characteristic analysis showed that baseline urinary L-FABP exhibited 100 % sensitivity and 81.8 % specificity for predicting CI-AKI when the cutoff value was defined as 19.0 μg/gCr. Interestingly, the incidence of CI-AKI after CAG or PCI was reduced in the RA-HDF group in a comparison with 41 control patients (12 % vs 27 %) with eGFR level <45 ml/min/1.73 m(2) who underwent PCI before the introduction of RA-HDF. In conclusion, baseline L-FABP levels can be a predictor for occurrence of CI-AKI. We suggest that RA-HDF may prevent the development of CI-AKI in patients with severe renal dysfunction undergoing coronary procedures, although further large-scale prospective study is necessary to confirm our conclusions.
尽管造影剂诱导的急性肾损伤(CI-AKI)对患者的预后有很大影响,但关于接受造影血管造影的严重肾功能不全患者中CI-AKI的预测因素的数据却很少。因此,我们前瞻性地研究了25例肾功能不全患者,其定义为估计肾小球滤过率(eGFR)水平<45 ml/min/1.73 m²,这些患者接受了冠状动脉造影(CAG)或经皮冠状动脉介入治疗(PCI)。我们采用了从右心房吸出血液的血液透析滤过(RA-HDF)。CI-AKI组基线时尿肝型脂肪酸结合蛋白(L-FABP)的平均水平显著高于非CI-AKI组(59.8±45.6 vs 13.4±11.9 μg/gCr,P = 0.0003)。多因素回归分析表明,基线尿L-FABP是CI-AKI的独立显著预测因素(β = 0.741,P = 0.013)。受试者操作特征分析显示,当临界值定义为19.0 μg/gCr时,基线尿L-FABP对预测CI-AKI的敏感性为100%,特异性为81.8%。有趣的是,与41例在引入RA-HDF之前接受PCI且eGFR水平<45 ml/min/1.73 m²的对照患者相比,RA-HDF组在CAG或PCI后CI-AKI的发生率降低(12% vs 27%)。总之,基线L-FABP水平可作为CI-AKI发生的预测指标。我们认为,RA-HDF可能预防接受冠状动脉手术的严重肾功能不全患者发生CI-AKI,尽管需要进一步的大规模前瞻性研究来证实我们的结论。